Suppr超能文献

蛋白激酶C激活与α2-自受体调节的去甲肾上腺素释放

Protein kinase C activation and alpha 2-autoreceptor-modulated release of noradrenaline.

作者信息

Allgaier C, Hertting G, Huang H Y, Jackisch R

机构信息

Pharmakologisches Institut der Universität, Freiburg i. Br., Federal Republic of Germany.

出版信息

Br J Pharmacol. 1987 Sep;92(1):161-72. doi: 10.1111/j.1476-5381.1987.tb11308.x.

Abstract

1 Effects of phorbol esters on the evoked noradrenaline release were studied in slices of the rabbit hippocampus, labelled with [3H]-noradrenaline, superfused continuously with a medium containing the reuptake inhibitor cocaine and stimulated electrically for 2 min (stimulation parameters: 2 ms, 24 mA, 5 V cm-1, 3 or 0.3 Hz). 2 The electrically-evoked overflow of [3H]-noradrenaline in the slices was increased in a concentration-dependent manner by the protein kinase C (PKC) activators 12-O-tetradecanoylphorbol 13-acetate (TPA) and 4 beta-phorbol 12,13-dibutyrate (4 beta-PDB). Phorbol esters, which do not activate PKC, 4-O-methyl-TPA and 4 alpha-PDB, showed no effect on neurotransmitter release. The effect of 4 beta-PDB was abolished in the presence of tetrodotoxin and in the absence of calcium. The PKC inhibitor polymyxin B inhibited the evoked noradrenaline release. 3 In the presence of 4 beta-PDB the inhibitory effects of the alpha 2-adrenoceptor agonist clonidine or the facilitatory effects of the alpha 2-adrenoceptor antagonist yohimbine seemed to be modified only by changes in the concentration of noradrenaline in the synaptic region. At a stimulation frequency of 3 Hz the inhibitory action of clonidine was reduced whereas the facilitatory effect of the yohimbine was even slightly enhanced by the phorbol ester. At 0.3 Hz and in the presence of 4 beta-PDB the effect of clonidine remained and that of yohimbine was strongly enhanced. 4 Pretreatment of the slices with islet-activating protein or N-ethylmaleimide significantly reduced the enhancement of noradrenaline release caused by 4 beta-PDB. It is possible that a regulatory N-protein is involved in steps following PKC activation. 5 These results suggest that PKC participates in the mechanism of action-potential-induced noradrenaline release from noradrenergic nerve terminals of the rabbit hippocampus and that effects on the autoinhibitory feedback system were not responsible for the 4 beta-PDB-induced increase of neurotransmitter release.

摘要
  1. 研究了佛波酯对兔海马切片中诱发去甲肾上腺素释放的影响。这些切片用[3H] - 去甲肾上腺素标记,连续灌流含有再摄取抑制剂可卡因的培养基,并电刺激2分钟(刺激参数:2毫秒,24毫安,5伏/厘米,3或0.3赫兹)。2. 蛋白激酶C(PKC)激活剂12 - O - 十四烷酰佛波醇13 - 乙酸酯(TPA)和4β - 佛波醇12,13 - 二丁酸酯(4β - PDB)以浓度依赖的方式增加了切片中[3H] - 去甲肾上腺素的电诱发溢出。不激活PKC的佛波酯4 - O - 甲基 - TPA和4α - PDB对神经递质释放无影响。4β - PDB的作用在存在河豚毒素和无钙的情况下被消除。PKC抑制剂多粘菌素B抑制诱发的去甲肾上腺素释放。3. 在存在4β - PDB的情况下,α2 - 肾上腺素能受体激动剂可乐定的抑制作用或α2 - 肾上腺素能受体拮抗剂育亨宾的促进作用似乎仅通过突触区域去甲肾上腺素浓度的变化而改变。在3赫兹的刺激频率下,可乐定的抑制作用减弱,而育亨宾的促进作用甚至因佛波酯而略有增强。在0.3赫兹且存在4β - PDB的情况下,可乐定的作用仍然存在,育亨宾的作用则强烈增强。4. 用胰岛激活蛋白或N - 乙基马来酰亚胺预处理切片可显著降低4β - PDB引起的去甲肾上腺素释放增强。可能有一个调节性N蛋白参与PKC激活后的步骤。5. 这些结果表明,PKC参与了兔海马去甲肾上腺素能神经末梢动作电位诱导的去甲肾上腺素释放机制,并且对自身抑制反馈系统的影响不是4β - PDB诱导神经递质释放增加的原因。

相似文献

引用本文的文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验